Oncotelic Therapeutics, Inc. Net Income (Loss) Available to Common Stockholders, Basic
Oncotelic Therapeutics, Inc. (OTLC) reported Net Income (Loss) Available to Common Stockholders, Basic of -$12.65 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-30.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2015-03-30
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2014-12-31 was -$2.64M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2014-09-30 was -$3.45M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2014-06-30 was -$3.93M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2014-03-31 was -$2.63M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for fiscal 2014 was -$12.65M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for fiscal 2013 was -$13.08M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for fiscal 2012 was -$8.08M.
- Oncotelic Therapeutics, Inc. net income (loss) available to common stockholders, basic for fiscal 2011 was -$9.65M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$6.09M derived: sum of 2 quarters · filed 2015-03-30 | -$10.02M derived: sum of 3 quarters · filed 2015-03-30 | -$12.65M 10-K · filed 2015-03-30 |
| 2014-09-30 | -$3.45M 10-Q · filed 2014-11-13 | -$7.38M derived: sum of 2 quarters · filed 2014-11-13 | -$10.01M 10-Q · filed 2014-11-13 | -$12.11M derived: sum of 4 quarters · filed 2015-03-30 |
| 2014-06-30 | -$3.93M 10-Q · filed 2014-08-08 | -$6.56M 10-Q · filed 2014-08-08 | -$8.66M derived: sum of 3 quarters · filed 2015-03-30 | -$13.62M derived: sum of 4 quarters · filed 2015-03-30 |
| 2014-03-31 | -$2.63M derived: 10-K 12 month − 3 quarters · filed 2015-03-30 | -$4.73M derived: sum of 2 quarters · filed 2015-03-30 | -$9.69M derived: sum of 3 quarters · filed 2015-03-30 | -$13.83M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-12-31 | -$2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$7.06M derived: sum of 2 quarters · filed 2015-03-30 | -$11.20M derived: sum of 3 quarters · filed 2015-03-30 | -$13.08M 10-K · filed 2015-03-30 |
| 2013-09-30 | -$4.96M 10-Q · filed 2014-11-13 | -$9.10M derived: sum of 2 quarters · filed 2014-11-13 | -$10.98M 10-Q · filed 2014-11-13 | |
| 2013-06-30 | -$4.13M 10-Q · filed 2014-08-08 | -$6.01M 10-Q · filed 2014-08-08 | ||
| 2012-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$3.92M derived: sum of 2 quarters · filed 2015-03-30 | -$6.19M derived: sum of 3 quarters · filed 2015-03-30 | -$8.08M 10-K · filed 2015-03-30 |
| 2012-09-30 | -$2.25M 10-Q · filed 2013-11-13 | -$4.51M derived: sum of 2 quarters · filed 2013-11-13 | -$6.40M 10-Q · filed 2013-11-13 | |
| 2012-06-30 | -$2.27M 10-Q/A · filed 2013-10-18 | -$4.16M 10-Q/A · filed 2013-10-18 | ||
| 2011-12-31 | -$9.65M 10-K · filed 2014-03-20 | |||
| 2010-12-31 | -$23.77M 10-K · filed 2012-03-28 | |||
| 2009-12-31 | -$35.11M 10-K · filed 2012-03-28 |